NewsMeter
CVS Health beat Wall Street estimates and raised its guidance, citing continued improvement in the company's insurance unit as the key driver.
The company also announced a collaboration with Eli Lilly to make Zepbound and Foundayo accessible to eligible patients on the CVS Health app.
Insurance unit: the segment behind the raised outlook The insurance unit's ongoing improvement is what CVS Health credited for both the analyst estimate beat and the revised guidance.
A guidance hike following a consensus beat signals that management expects the forces behind the outperformance to hold, not reverse.
Keep reading